Comparing Two Methods of Subacromial Space Injection

September 28, 2018 updated by: Vasantha Kumar Ramsingh, Aneurin Bevan University Health Board

Comparing Two Methods of Subacromial Space Injection - A Randomised Blinded Trial

Subacromial shoulder injections can be approached from the front or side of the shoulder. The investigators are comparing both methods, to find which one has better spread in the subacromial space.

Study Overview

Status

Unknown

Intervention / Treatment

Detailed Description

Both lateral and posterio-lateral methods of subacromial injections are widely used for diagnostic and therapeutic purposes. It is not known which method allows the most accurate access into the subacromial space and is more effective.

The investigators have been using a novel approach from the anterior aspect of the shoulder for years with good clinical effect and propose comparing this approach to the described approach. This study will indicate which method is best and will be of practical clinical importance. The investigators feel the technique is easier to perform than other described methods and could be taught to clinicians throughout the country and adopted as the standard approach.

Study Type

Interventional

Enrollment (Anticipated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Newport, United Kingdom, NP202UB
        • Recruiting
        • Aneurin Bevan University Health Board
        • Contact:
        • Principal Investigator:
          • Vasantha kumar Ramsingh, FRCS

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Shoulder pain for at least 6 weeks duration along the lateral aspect of the shoulder.
  • Positive impingement signs.

Exclusion Criteria:

  • History of compensation claim due to shoulder problems.
  • Allergy to radiographic dye.
  • Recent shoulder fracture.
  • Bleeding disorder.
  • Previous shoulder surgery.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Anterior portal
Injection in to subacromial space from anterior portal
Injection in to subacromial space in the shoulder from anterior portal
Active Comparator: Lateral portal
Injection in to subacromial space from lateral portal
Injection in to subacromial space in the shoulder from anterior portal

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The spread of dye in subacromial space
Time Frame: With in One hour
The participants will go for an X ray following injection which contains a radio-opaque dye to demonstrate the spread of injected material (Local anaesthetic, depomedrone and Niopam dye) in the subacromial space. A blinded radiologist will read the radiographs and scale the distribution of dye from 1 to 4 depending on the location of radiopaque dye.
With in One hour

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain control after subacromial injection
Time Frame: With in One hour
The participants will fill a visual analog score before and after injection to assess the pain relief after injection.
With in One hour

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 6, 2017

Primary Completion (Anticipated)

February 20, 2019

Study Completion (Anticipated)

February 20, 2019

Study Registration Dates

First Submitted

September 3, 2018

First Submitted That Met QC Criteria

September 28, 2018

First Posted (Actual)

October 2, 2018

Study Record Updates

Last Update Posted (Actual)

October 2, 2018

Last Update Submitted That Met QC Criteria

September 28, 2018

Last Verified

September 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • IRAS194489

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Subacromial Impingement Syndrome

Clinical Trials on Subacromial Injection

3
Subscribe